Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1
The Journal of Gene Medicine · 2024
DOI: 10.1002/jgm.3669 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2024. Verfasst von Zhihao Wen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Ferroptosis, Head and Neck Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Hubei Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Background
This study investigated the role of the ferroptosis‐related gene FTH1 in oral squamous cell carcinoma (OSCC) and evaluated the therapeutic potential of baicalin in OSCC cell treatment.
Methods
A prognostic model was established by bioinformatic analysis, consisting of 12 ferroptosis related genes (FRGs), and FTH1 was selected as the most significantly up‐regulated FRGs. The clinical correlation of FTH1 in OSCC samples was evaluated by both immunohistochemical and bioinformatic characterizations. The effects of FTH1 on migration, invasion, epithelial–mesenchymal transition (EMT) and proliferation were determined by wound healing assays, transwell assays, western blotting and 5′‐ethynl 2′‐deoxyuridine proliferation assays, respectively. The effects of FTH1 on ferroptosis were tested via ferroptosis markers and Mito Tracker staining. In addition, the therapeutic effects of baicalin on OSCC cells were confirmed using EMT, migration, invasion, proliferation and ferroptosis assays.
Results
The 12 FRGs were predictive of the prognosis for OSCC patients, and FTH1 expression was identified as significantly up‐regulated in OSCC samples, which was highly associated with survival, immune cell infiltration and drug sensitivity. Moreover, knocking down FTH1 inhibited cell proliferation, EMT and invasive phenotypes, but induced ferroptosis in OSCC cells (Cal27 and SCC25). Furthermore, baicalin directly suppressed expression of FTH1 in OSCC cells, and effectively promoted ferroptosis and inhibited the proliferation as well as EMT by directly targeting FTH1.
Conclusions
This study has demonstrated that FTH1 is a therapeutic target for OSCC treatment, and has provided evidence that baicalin offers a promising alternative for OSCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan, China.
- Kunming Medical University, Kunming, China.
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Förderung
- Hubei Provincial Natural Science Foundation of China
Zitieren
APA
Wen, Z., Zhang, Y., Gao, B., & Chen, X. (2024). Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3669
Vancouver
Wen Z, Zhang Y, Gao B, Chen X. Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1. The Journal of Gene Medicine. 2024. doi:10.1002/jgm.3669
BibTeX
@article{Wen2024,
author = {Wen, Zhihao and Zhang, Yuxiao and Gao, Bo and Chen, Xin},
title = {Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1},
journal = {The Journal of Gene Medicine},
year = {2024},
doi = {10.1002/jgm.3669}
}
EUVIMED